SCHEMBL541607

SCHEMBL541607

C=C(C)C(=O)OCCC(CC[N+](C)(C)C)OP(=O)(O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.37
CHRM5 P08912 4/20 0.37
CHRM1 P11229 4/20 0.37
CHRM3 P20309 4/20 0.37
TSHR P16473 4/20 0.36
CHRM2 P08172 3/20 0.34
CHRM4 P08173 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HTR1A P08908 2/20 0.34
CHRNB2 P17787 2/20 0.34
CHRNA7 P36544 2/20 0.34
CHRNA4 P43681 2/20 0.34
PGR P06401 1/20 0.34
TBXA2R P21731 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA10 Q9GZZ6 1/20 0.34
CHRNA9 Q9UGM1 1/20 0.34
GALR3 O60755 2/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL541465 0.92 TSHR (0.41) THRBCHRM5CHRM1CHRM3TSHR
SCHEMBL541116 0.92 TSHR (0.38) THRBCHRM5CHRM1CHRM3TSHR
SCHEMBL541380 0.91 TSHR (0.43) THRBCHRM5CHRM1CHRM3TSHR
SCHEMBL541209 0.90 TSHR (0.46) THRBCHRM5CHRM1CHRM3TSHR
SCHEMBL541396 0.90 TSHR (0.46) THRBCHRM5CHRM1CHRM3TSHR
SCHEMBL3652753 0.89 THRB (0.39) THRBTSHRALDH1A1
SCHEMBL3655604 0.88 TSHR (0.43) THRBTSHRALDH1A1
SCHEMBL176508 0.87 THRB (0.38) THRBCHRM5CHRM1CHRM3TSHR
SCHEMBL541476 0.86 TSHR (0.41) THRBCHRM5CHRM1CHRM3TSHR
SCHEMBL3649219 0.86 TSHR (0.48) THRBTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240189121-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2024-06-13 US claimed
EP-3666299-B1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP (US) 2024-05-15 EP claimed
US-11903850-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2024-02-20 US claimed
US-20230036800-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2023-02-02 US claimed
US-11406514-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2022-08-09 US claimed
US-20220227954-A1 POLYMERIC SURFACE HAVING REDUCED BIOMOLECULE ADHESION TO THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE OAKTREE FUND ADMINISTRATION, LLC 2022-07-21 US claimed
US-11369497-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2022-06-28 US claimed
EP-3862384-A2 POLYMERIC SUBSTRATE WITH A SURFACE HAVING REDUCED BIOMOLECULE ADHESION, AND THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE SiO2 Medical Products, Inc. (US) 2021-08-11 EP claimed
US-20210068991-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2021-03-11 US claimed
US-10835393-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2020-11-17 US claimed
EP-3400973-A1 METHOD OF MANUFACTURING ANTI-THROMBOGENIC MEDICAL DEVICES Covidien LP (US) 2018-11-14 EP claimed
EP-2875833-B1 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2018-08-08 EP claimed
US-20170232156-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2017-08-17 US claimed
US-9668890-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2017-06-06 US claimed
US-20150148882-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2015-05-28 US claimed
EP-2875833-A1 Anti-thrombogenic medical devices and methods Covidien LP (US) 2015-05-27 EP claimed
US-20150140344-A1 COATED MEDICAL DEVICES COVIDIEN LP 2015-05-21 US claimed
US-20100094339-A1 COATING COMPOSITIONS COVIDIEN LP 2010-04-15 US claimed
EP-2120824-A1 COATING COMPOSITIONS Tyco Healthcare Group LP (US) 2009-11-25 EP claimed
WO-2008143654-A1 COATING COMPOSITIONS TYCO HEALTHCARE GROUP LP (US) 2008-11-27 WO claimed